Lv11
40 积分 2023-07-26 加入
Etoposide addition and brentuximab vedotin consolidation in first-line treatment of CD30-positive peripheral T-cell lymphoma: can we improve BV–CHP?
7天前
已完结
Structural and functional characterization of Acyl-CoA Synthetase Long-Chain Family Member 3 (ACSL3) and its targeted inhibition by gramicidin in multiple myeloma
8天前
已完结
PCIF1-mediated m6Am modification activates USP5/BRD4 axis to promote glycolysis-driven immunosuppression in multiple myeloma
9天前
已完结
A metabolically reprogrammable nanoplatform potentiates photodynamic immunotherapy through glycolytic blockade
9天前
已完结
Targeting metabolic reprogramming and epigenetic remodeling: a novel strategy to reshape the immune microenvironment in multiple myeloma
9天前
已完结
DRP1-mediated mitochondrial fragmentation is a druggable vulnerability in multiple myeloma
14天前
已完结
Reducing ventilator associated pneumonia in adult patients through high standards of oral care: a historical control study
1个月前
已完结
Long-Term Follow-Up of Chidamide With Chemotherapy in Untreated Peripheral T-Cell Lymphoma: One Single Center Real-World Study in China
1个月前
已完结
Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 study
1个月前
已完结
Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)
1个月前
已完结
皖公网安备34019202002308
